Showing 1 to 1 of 1 results
npr.org
🌐 75% Global Worthiness
Leqembi's Varied Efficacy in Alzheimer's Treatment Highlighted by Patient Case
Sue Bell, diagnosed with early-stage Alzheimer's in 2019, participated in a Leqembi clinical trial from 2020 to 2024, experiencing varied treatment benefits before discontinuing due to declining efficacy, highlighting the drug's limitations despite its approval in 2023.
Leqembi's Varied Efficacy in Alzheimer's Treatment Highlighted by Patient Case
Sue Bell, diagnosed with early-stage Alzheimer's in 2019, participated in a Leqembi clinical trial from 2020 to 2024, experiencing varied treatment benefits before discontinuing due to declining efficacy, highlighting the drug's limitations despite its approval in 2023.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results